A Phase 3, Multicenter, 3-Week Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy, Safety And Pharmacokinetic Study Of Evening Dosed Methylphenidate Hydrochloride Extended-Release Capsules (Hld200) In Children Aged 4 To 5 Ye
Posted Date: Jan 7, 2025
- Investigator: Melissa Delbello
- Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology
- Type of Study: Drug
The purpose of this research is to learn more about the study medicine, methylphenidate hydrochloride extended-release capsules and whether it is beneficial for children 4 to 5 years of age with ADHD. The study will examine whether the study medicine is tolerable, how it works in the body, and whether it can treat ADHD symptoms the way it was designed.
Criteria:
Null
Keywords:
Attention Deficit Hyperactivity Disorder, Children
For More Information:
Raechel Cooley
513 558-6205
cooleyra@uc.edu